NEVVI Medicare utilization intelligence

← back

BURCH, MICAHM.D. NPI 1932367893 Clinician

Medical Oncology · DALLAS, TX

Specialty Medical Oncology — from billed Medicare claims
Trained UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 20 years since medical school (class of 2006, self-reported to CMS)
Location DALLAS, TX · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 58 codes billed · 37,835 disclosed volume (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
TEXAS ONCOLOGY PA
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2014-08

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed submitted charges across all codes were in CY2024. Included with Platform.

  • Charge, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J2469 Injection, palonosetron hcl, 25 mcg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
88185 Flow cytometry technique for dna or cell analysis, each additional marker
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1626 Injection, granisetron hydrochloride, 100 mcg
J0640 Injection, leucovorin calcium, per 50 mg
83521 Measurement of immunoglobulin light chains
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
82728 Ferritin (blood protein) level
J9190 Injection, fluorouracil, 500 mg
83540 Iron level
83550 Iron binding capacity
96375 Injection of additional new drug or substance into vein
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
J9045 Injection, carboplatin, 50 mg
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
85055 Reticulated (young) platelet measurement
83615 Lactate dehydrogenase (enzyme) level
J3489 Injection, zoledronic acid, 1 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J3475 Injection, magnesium sulfate, per 500 mg
85045 Red blood count, automated test
96372 Injection of drug or substance under skin or into muscle
82784 Gammaglobulin (immune system protein) measurement
J1200 Injection, diphenhydramine hcl, up to 50 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
J7030 Infusion, normal saline solution , 1000 cc
J3490 Unclassified drugs
71260 Ct scan of chest with contrast
74177 Ct scan of abdomen and pelvis with contrast
82607 Cyanocobalamin (vitamin b-12) level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96361 Infusion into a vein for hydration, each additional hour
88184 Flow cytometry technique for dna or cell analysis, first marker
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96523 Irrigation of implanted venous access drug delivery device
71250 Ct scan of chest without contrast
80048 Blood test, basic group of blood chemicals (calcium, total)

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.